Prostate Cancer - Results from #24720

Prostate cancer: Germline prediction for a commonly variable malignancy - Abstract October 5, 2012

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: Data from ethnic Chinese patients with localized prostate cancer - Abstract October 5, 2012

Cognitive problems in patients on androgen deprivation therapy: A qualitative pilot study - Abstract October 5, 2012

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials - Abstract October 5, 2012

Influence of the number of elongated fiducial markers on the localization accuracy of the prostate - Abstract October 5, 2012

Role of early proctoscopy in predicting late symptomatic proctitis after external radiation therapy for prostate carcinoma - Abstract October 5, 2012

Kilovoltage intrafraction monitoring for prostate intensity modulated arc therapy: First clinical results - Abstract October 5, 2012

First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: First results - Abstract October 5, 2012

Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: Results from a phase II trial (SAKK 08/07) - Abstract October 5, 2012

Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma - Abstract October 5, 2012

Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume - Abstract October 4, 2012

Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate? - Abstract October 4, 2012

Exploring patient perceptions of PSA screening for prostate cancer: Risks, effectiveness, and importance - Abstract October 4, 2012

Health-related quality-of-life findings for the Prostate Cancer Prevention Trial - Abstract October 4, 2012

Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): A cross-sectional study in over 500 patients - Abstract October 4, 2012

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer - Abstract October 4, 2012

Prostate cancer detection via transrectal ultrasound biopsy: Vienna nomogram versus sextant/octant biopsy methods - Abstract October 4, 2012

Intravesical ropivacaine as a novel means of analgesia post robot assisted radical prostatectomy: A randomized, double blind, placebo controlled trial - Abstract October 4, 2012

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: Association with outcome and predictive nomogram - Abstract October 4, 2012

Testosterone replacement therapy in the setting of prostate cancer treated with radiation - Abstract October 4, 2012

Page 1237 of 1438